If you regularly reach for diphenhydramine to fall asleep — sold under names like Benadryl, ZzzQuil, Tylenol PM, and Advil PM — there is growing evidence that long-term use may be raising your risk of dementia. A landmark 2015 study published in JAMA Internal Medicine followed over 3,400 adults aged 65 and older for more than seven years and found that those with the highest cumulative use of anticholinergic drugs like diphenhydramine had a 54 percent increased risk of developing dementia compared to people who did not use them. That is not a small number, and it is not based on a single study — multiple large-scale investigations have reached similar conclusions. This does not mean that taking a Benadryl once before a red-eye flight is going to give you Alzheimer’s disease.
The risk is cumulative, meaning it builds over months and years of regular use. But the problem is that millions of Americans treat diphenhydramine like a harmless nightly ritual, not realizing it belongs to a class of drugs that directly interferes with a brain chemical essential for memory. A 2025 expert consensus review confirmed that diphenhydramine is appropriate only for short-term insomnia relief and should not be used as a long-term sleep solution. In this article, we will break down exactly how diphenhydramine affects the brain, what the research actually says about dose and duration thresholds, who faces the greatest risk, and what safer alternatives exist for people struggling with chronic sleep problems.
Table of Contents
- How Does This Common Sleep Aid Damage Your Brain Over Time?
- What the Research Says About Dose, Duration, and Dementia Risk
- Who Faces the Greatest Risk From Long-Term Use?
- Safer Sleep Alternatives That Do Not Carry Cognitive Risk
- The Difference Between Occasional Use and Chronic Dependence
- What to Tell Your Doctor If You Have Been Using Diphenhydramine Long-Term
- Where the Science Goes From Here
- Conclusion
- Frequently Asked Questions
How Does This Common Sleep Aid Damage Your Brain Over Time?
Diphenhydramine works by blocking acetylcholine, a neurotransmitter that your brain depends on for attention, learning, and short-term memory. That is actually why the drug makes you drowsy — it suppresses a chemical signaling system that helps keep you alert and cognitively sharp. In the short term, this produces the familiar grogginess and mental fog that people experience the morning after taking it. Over the long term, chronically suppressing acetylcholine appears to have consequences that do not simply reverse when you stop taking the pill. To understand why this matters, consider what happens in Alzheimer’s disease. One of the hallmarks of Alzheimer’s is a severe decline in cholinergic function — the very system that diphenhydramine suppresses.
In fact, several Alzheimer’s medications work by doing the exact opposite of what diphenhydramine does: they boost acetylcholine levels. So taking a drug that blocks acetylcholine every night for years is, in a crude sense, pushing the brain in the opposite direction of the drugs designed to treat dementia. The 2015 JAMA study found that among participants who developed dementia, nearly 80 percent were diagnosed with Alzheimer’s disease specifically, which strengthens the concern about cholinergic disruption as a potential mechanism. It is worth noting that diphenhydramine is not the only anticholinergic drug out there. Certain medications for overactive bladder, older antidepressants, and some muscle relaxants also have anticholinergic properties. But diphenhydramine stands out because of how widely and casually it is used — it is the number one over-the-counter sleep aid ingredient in the United States, and many people have no idea it carries any cognitive risk at all.
What the Research Says About Dose, Duration, and Dementia Risk
The evidence linking anticholinergic sleep aids to dementia is not based on a single alarming headline. Multiple studies over the past decade have built a consistent picture. The 2015 study by Gray and colleagues tracked 3,434 participants aged 65 and older in the Seattle area over a mean follow-up period of 7.3 years. Those with the highest cumulative anticholinergic exposure — equivalent to taking a standard dose daily for more than three years — had a 54 percent increased risk of dementia, with an adjusted hazard ratio of 1.54. The study was carefully designed to account for confounding factors like age, sex, and other health conditions. A 2019 study by Coupland and colleagues, also published in JAMA Internal Medicine, added further weight. This nested case-control study found a dose-response pattern: the more cumulative anticholinergic exposure a person had, the higher their risk climbed. At minimal exposure, the increased risk was modest — about 6 percent.
But at the highest levels of cumulative use, exceeding 1,095 total standardized daily doses, the risk rose to 49 percent. A 2021 systematic review and meta-analysis confirmed that the association between anticholinergic drug use and increased dementia risk held up across multiple independent studies. However, there is an important caveat that honest reporting demands. These studies show a strong association, but they do not definitively prove causation. It is possible that some portion of the observed link is explained by reverse causation — meaning that people in the early, undetected stages of dementia may already be experiencing sleep disruption, which leads them to use more sleep aids before they are ever diagnosed. Researchers have worked to control for this possibility, but it cannot be entirely eliminated from observational studies. That said, the biological plausibility of the anticholinergic mechanism, combined with the consistency of findings across studies, is enough that most experts now advise against chronic use.
Who Faces the Greatest Risk From Long-Term Use?
Adults over 65 are the most vulnerable population, and this is where the research evidence is strongest. The American Geriatrics Society includes diphenhydramine on the Beers Criteria, a widely referenced list of medications that older adults should generally avoid. The Beers Criteria exist specifically because certain drugs pose disproportionate risks to aging bodies and brains, and anticholinergics are flagged not only for cognitive effects but also for increasing fall risk, causing urinary retention, and producing confusion. Consider a common scenario: a 68-year-old retiree develops trouble sleeping after her spouse passes away. Her doctor is busy, and a box of ZzzQuil is right there on the pharmacy shelf. She starts taking it nightly. One year becomes three, and three becomes six.
She may notice increasing forgetfulness but attributes it to normal aging. According to the research, daily doses of 50 mg of diphenhydramine for over three years, or even 25 mg for more than six years, are enough to notably elevate dementia risk. By the time anyone connects her nightly sleep aid to her cognitive decline, years of cumulative exposure have already occurred. Younger adults are not entirely off the hook, either. While the major studies focused on participants over 65, the dose-response relationship suggests that cumulative exposure at any age adds up. A 40-year-old who takes diphenhydramine nightly for two decades is building a significant lifetime anticholinergic burden. The brain does not reset its exposure counter at age 65 — it carries forward.
Safer Sleep Alternatives That Do Not Carry Cognitive Risk
If you are looking for a replacement, the good news is that options exist that do not interfere with acetylcholine. Melatonin is the most accessible over-the-counter alternative. It works by regulating the body’s sleep-wake cycle rather than sedating the brain, and it has no anticholinergic properties. Studies have not linked melatonin to increased dementia risk. The tradeoff is that melatonin is generally less potent as a knock-you-out sleep aid — it works best when taken consistently at the same time each evening, and it is more effective for people whose circadian rhythms are misaligned than for those with anxiety-driven insomnia.
For people with chronic insomnia, cognitive behavioral therapy for insomnia, known as CBT-I, is considered the gold standard by most sleep medicine experts. CBT-I addresses the underlying thought patterns and behaviors that perpetuate poor sleep — things like clock-watching, spending too long in bed, and associating the bedroom with anxiety. It is more effective than any pill over the long term, and it carries zero pharmacological risk. The downside is access: CBT-I typically requires a trained therapist, though digital CBT-I programs have become increasingly available. The comparison is stark — diphenhydramine offers immediate sedation at the cost of potential long-term brain harm, while CBT-I requires patience and effort but produces durable improvement without side effects.
The Difference Between Occasional Use and Chronic Dependence
One of the most important distinctions in this conversation is between taking diphenhydramine once in a while and taking it every night. The 2025 expert consensus review, published in the Journal of Clinical Medicine, concluded that diphenhydramine is effective for acute or short-term insomnia and that occasional use is generally not considered problematic beyond next-day grogginess. The research linking the drug to dementia risk consistently points to cumulative, long-term exposure as the driver of increased risk. The danger lies in how easily occasional use slides into nightly dependence.
Diphenhydramine loses effectiveness relatively quickly as the body builds tolerance, which means people often increase their dose to get the same effect — exactly the pattern that accelerates cumulative exposure. Someone who started with 25 mg a few nights a week may find themselves taking 50 mg or more every single night within a few months. If you have been using diphenhydramine nightly for more than a few weeks, that is a signal to talk to your doctor rather than simply increasing the dose. Abruptly stopping can also cause rebound insomnia, which can make the problem feel worse before it gets better and tempt people back to the pill bottle.
What to Tell Your Doctor If You Have Been Using Diphenhydramine Long-Term
If you have been taking diphenhydramine or a product containing it for months or years, bring it up at your next medical appointment — even if your doctor has never asked about it. Many physicians do not routinely screen for over-the-counter anticholinergic use because patients often do not think of OTC products as “real” medications worth mentioning.
Be specific about the dose and how long you have been taking it. For example, telling your doctor “I have been taking two Tylenol PM every night for the past four years” gives them concrete information to work with. Your doctor can help you taper off safely and explore alternatives tailored to your specific sleep issues, whether that is melatonin, a prescription sleep aid with a different mechanism, or a referral for CBT-I.
Where the Science Goes From Here
Researchers are working to clarify the remaining open questions — most importantly, whether the association between anticholinergic use and dementia represents true causation or is partly explained by reverse causation and confounding factors. Longer-term prospective studies with more rigorous controls for early dementia symptoms are underway. There is also growing interest in developing anticholinergic burden scoring tools that could help pharmacists and doctors flag patients whose total medication load poses cognitive risk, since many people take multiple drugs with mild anticholinergic effects that compound each other.
In the meantime, the practical guidance is clear enough. The evidence may not yet constitute absolute proof, but it is strong enough and consistent enough that no sleep medicine expert recommends chronic diphenhydramine use. The precautionary principle applies: when a safer alternative exists and the potential downside of the current option is dementia, the rational choice is to switch.
Conclusion
The bottom line is that diphenhydramine — the active ingredient in Benadryl, ZzzQuil, Tylenol PM, and similar products — is not the harmless sleep aid that most people assume it to be. Multiple large studies have demonstrated that long-term, cumulative use is associated with a significantly increased risk of dementia, potentially as high as 54 percent in the heaviest users. The drug works by blocking acetylcholine, a neurotransmitter critical to memory and learning, and chronic suppression of this system appears to have consequences that go well beyond next-day drowsiness.
If you use diphenhydramine occasionally for a rough night of sleep, the current evidence suggests you are probably fine. But if it has become a nightly habit — especially if you are over 65 or approaching that age — it is time to have a frank conversation with your doctor about alternatives. Melatonin and CBT-I are both effective options that do not carry anticholinergic risk. Your brain is not something you want to gamble with for the sake of convenience, especially when the stakes may include your long-term ability to remember the people and experiences that matter most to you.
Frequently Asked Questions
Does taking Benadryl once in a while cause dementia?
No. The research consistently points to cumulative, long-term use as the risk factor. A 2025 expert consensus review confirmed that occasional use is generally not considered problematic beyond next-day grogginess. The concern is with daily use sustained over months and years.
How much diphenhydramine is considered dangerous for brain health?
The studies identified threshold doses of approximately 50 mg daily for over three years, or 25 mg daily for more than six years, as significantly elevating dementia risk. The 2019 Coupland study found a dose-response relationship, with risk climbing alongside cumulative exposure.
Is melatonin a safe alternative to diphenhydramine for sleep?
Melatonin is considered a safer OTC substitute. It regulates sleep-wake cycles without blocking acetylcholine and has not been linked to increased dementia risk. However, it may be less immediately sedating than diphenhydramine and works best when taken consistently at the same time each night.
Can the brain damage from long-term diphenhydramine use be reversed?
This remains an open question in the research. Some studies suggest that cognitive effects may partially improve after discontinuation, but it is unclear whether the elevated dementia risk fully reverses. The longer and heavier the cumulative use, the less likely complete reversal becomes, which is why early discontinuation matters.
Are prescription sleep aids safer than diphenhydramine for long-term use?
Some prescription sleep aids operate through different mechanisms that do not involve anticholinergic activity, but all sleep medications carry their own risks and side effects. CBT-I remains the recommended first-line treatment for chronic insomnia because it addresses the root causes of poor sleep without any pharmacological risk.
I am under 50 — should I still be concerned?
The major studies focused on adults over 65, but the risk is cumulative over a lifetime. A younger person who uses diphenhydramine nightly for decades is building significant anticholinergic exposure that they carry into older age. Starting safer sleep habits earlier is always preferable.
